5 F), although this difference did not reach statistical significance, suggesting a potential role for TYRO3 inhibition in delaying tumor recurrence.
← all excerpts
Targeting TYRO3 attenuates apoptotic cell-driven cancer stemness in triple negative breast cancer.
2
—
—
The sentences
However, survival analysis showed a trend toward delayed tumor recurrence in mice receiving the 5-FU + KRCT6j combination compared with the control and 5-FU monotherapy groups (Fig. 5 F), although this difference did not reach statistical significance, suggesting a potential role for TYRO3 inhibition in delaying tumor recurrence.